DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: In agreement with this interpretation, presynaptic dysferlin deficiency has been shown to reduce the ACh release and promote muscle changes reminiscent of LGMD2B dysferlinopathy [41] and it has been shown that dysferlin plays a critical role in the trafficking of proteins [24].